![Saulius Mecislovas Zemaitis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Saulius Mecislovas Zemaitis
Corporate Officer/Principal presso Pharmaswiss UAB
Profilo
Saulius Mecislovas Zemaitis is currently the General Manager-Baltic Countries at PharmaSwiss UAB since 2006.
Prior to this, he was the Chief Executive Officer at Sanitas AB.
Posizioni attive di Saulius Mecislovas Zemaitis
Società | Posizione | Inizio |
---|---|---|
Pharmaswiss UAB | Corporate Officer/Principal | 01/01/2006 |
Precedenti posizioni note di Saulius Mecislovas Zemaitis
Società | Posizione | Fine |
---|---|---|
Sanitas AB
![]() Sanitas AB Pharmaceuticals: MajorHealth Technology Sanitas AB manufactures pharmaceutical products. The company's main activities include manufacture and sale of carious generic medicine, development of new products, and toll manufacturing. Its products are divided into two categories namely Over the Counter and Prescription Products. Its Over the Counter Products consist of acetylsalicylic acid, alkostop, aprotinine, ascorbic acid, and argentum sulfathiazole. The firm's Prescrition Products include acetaminophen, paracetamol, coffein, aciclovirum natrium, aminophylline, and argentum sulfathiazole. The company was founded in 1922 and is headquartered in Kuanas, Lithuania. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Sanitas AB
![]() Sanitas AB Pharmaceuticals: MajorHealth Technology Sanitas AB manufactures pharmaceutical products. The company's main activities include manufacture and sale of carious generic medicine, development of new products, and toll manufacturing. Its products are divided into two categories namely Over the Counter and Prescription Products. Its Over the Counter Products consist of acetylsalicylic acid, alkostop, aprotinine, ascorbic acid, and argentum sulfathiazole. The firm's Prescrition Products include acetaminophen, paracetamol, coffein, aciclovirum natrium, aminophylline, and argentum sulfathiazole. The company was founded in 1922 and is headquartered in Kuanas, Lithuania. | Health Technology |
Pharmaswiss UAB |
- Borsa valori
- Insiders
- Saulius Mecislovas Zemaitis